Company page

Cordlife Group Limited

Cordlife Group Limited, traded under the ticker P8A, is a public company based in Singapore with a market capitalization of approximately SGD 24.9 million. The company specializes in cord blood and tissue banking services, providing families with options for preserving their newborn's stem cells. Cordlife aims to enhance healthcare outcomes through its innovative solutions in the field of regenerative medicine.